Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like Innoviva Board Recommends Shareholders Vote ???FOR??? All Of s Qualified Directors On The WHITE Proxy Card April 16, 2017 Publication Of Prospectus Relating To The Listing Of On Six Swiss Exchange June 8, 2017 3 Biotechs to Load Up on This Holiday Season November 30, 2017
Innoviva Board Recommends Shareholders Vote ???FOR??? All Of s Qualified Directors On The WHITE Proxy Card April 16, 2017
